September 13, 2010

Biotech companies Seattle Genetics and Genmab will collaborate to develop antibody treatments for cancer, the...

September 8, 2010

NEW YORK British drug maker GlaxoSmithKline and biotech company Genmab have started a late-stage trial...

August 31, 2010

The Food and Drug Administration has granted priority review for a diabetic macular edema treatment....

August 29, 2010

AstraZeneca's biologics unit has received a second complete response letter from the Food and Drug...

August 18, 2010

The Food and Drug Administration has decided to expedite the review of an investigational drug...

August 17, 2010

The Food and Drug Administration has agreed to expedite review of an investigational treatment for...

August 11, 2010

An investigational biotech drug didn’t significantly improve patients’ survival, according to results of a late-stage...

August 4, 2010

Biotech company Amgen had $3.8 billion in sales and $1.33 billion in profits during second...

August 1, 2010

Merck had global sales of $11.3 billion and profits of $752 million during second quarter...

July 20, 2010

A Food and Drug Administration advisory committee has voted to recommend limiting use of a...

July 18, 2010

The Food and Drug Administration has given priority review to an application from Amgen for...

July 12, 2010

A developer of a new drug for treating lupus has entered a supply agreement with...

June 30, 2010

British drug maker GlaxoSmithKline has inked a co-development and commercialization agreement with Genmab, the drug...

June 23, 2010

Reports of worsening conditions among patients has led drug maker Pfizer to suspend a clinical...

June 22, 2010

The Food and Drug Administration has approved a drug made by Genentech for treating a...

June 22, 2010

The Food and Drug Administration has granted orphan drug designation to an investigational treatment for...

June 21, 2010

Cases of the potentially deadly skin cancer melanoma are expected to almost double before the...

June 15, 2010

Drug maker OXiGENE has finished enrolling patients for a mid-stage clinical trial of a lung...

June 14, 2010

The Food and Drug Administration has agreed to speed up the review of a Genzyme...

June 14, 2010

Immunomedics has started a trial of an investigational drug for treating cancer of the plasma...

June 9, 2010

Human Genome Sciences has submitted an approval application for a treatment for lupus, development partner...

June 6, 2010

An investigational drug for skin cancer that had spread to other parts of the body...

May 24, 2010

Generic drug maker Teva Pharmaceutical Industries isn’t holding back in its effort to push into...

May 23, 2010

Swiss biotech company Biogen Idec and U.S. drug maker Abbott have begun enrolling patients in...